Diéras, V and Han, HS and Robson, ME and Palácová, M and Marcom, PK and Jager, A and Bondarenko, I and Citrin, D and Campone, M and Telli, ML and Domche, SM and Friedlander, M and Kaufman, B and Ratajczak, C and Coates, A and Bonnet, P and Qin, Q and Qian, J and Giranda, VL and Shepherd, SP and Puhalla, S and Isakoff, SJ (2017) Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer. Cancer Research, 77 (4 Supp). P42202-P42202. ISSN 0008-5472 (Print), 1538-7445 (Online)
|
Text
Poster Session Abstracts.pdf Download (592kB) | Preview |
Abstract
DOI: 10.1158/1538-7445.SABCS16-P4-22-02 Published February 2017
| Item Type: | Article |
|---|---|
| Additional Information: | http://cancerres.aacrjournals.org/content/77/4_Supplement/P4-22-02.short. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-22-02. |
| Subjects: | Oncology |
| Divisions: | Departments > Department of Oncology and Medical Radiology |
| Depositing User: | Елена Шрамко |
| Date Deposited: | 11 Sep 2017 07:32 |
| Last Modified: | 11 Sep 2017 08:46 |
| URI: | http://repo.dma.dp.ua/id/eprint/1932 |
Actions (login required)
 |
View Item |
